John Mackay - Sartorius Stedim Sales Marketing

0RG8 Stock   197.30  0.10  0.05%   

Executive

John Mackay is Sales Marketing of Sartorius Stedim Biotech
Age 61
Address Zone Industrielle Les Paluds, Aubagne, France, 13781
Phone33 4 42 84 56 00
Webhttps://www.sartorius.com

Sartorius Stedim Management Efficiency

The company has return on total asset (ROA) of 0.0313 % which means that it generated a profit of $0.0313 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0502 %, meaning that it generated $0.0502 on every $100 dollars invested by stockholders. Sartorius Stedim's management efficiency ratios could be used to measure how well Sartorius Stedim manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sartorius Stedim's Other Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 114.5 M in 2025, whereas Total Assets are likely to drop slightly above 2 B in 2025.

Similar Executives

Showing other executives

EXECUTIVE Age

Raj BhasinHochschild Mining plc
N/A
Rodrigo NunesHochschild Mining plc
N/A
John FallonDFS Furniture PLC
55
Elizabeth McDonaldDFS Furniture PLC
N/A
Samantha CampbellEndeavour Mining Corp
N/A
Eduardo NoriegaHochschild Mining plc
39
Joanne HalladayEcclesiastical Insurance Office
N/A
S ACIIEcclesiastical Insurance Office
N/A
Eduardo VillarHochschild Mining plc
52
Martin WhiteEndeavour Mining Corp
N/A
Sarah ACIIEcclesiastical Insurance Office
N/A
Jerry GatesBeazer Homes USA
N/A
Klaus Fahrnbergerbet at home AG
N/A
Emilie SchoutenCoeur Mining
46
BComm BComEcclesiastical Insurance Office
N/A
Steward SparksBeazer Homes USA
N/A
William JuneBeazer Homes USA
N/A
Djaria TraoreEndeavour Mining Corp
N/A
Alex SaldenDFS Furniture PLC
N/A
Elicia AzaliBeazer Homes USA
N/A
Rachael FCISEcclesiastical Insurance Office
N/A
Sartorius Stedim Biotech (0RG8) is traded on London Exchange in UK and employs 10,082 people. Sartorius Stedim is listed under Environmental & Facilities Services category by Fama And French industry classification.

Management Performance

Sartorius Stedim Biotech Leadership Team

Elected by the shareholders, the Sartorius Stedim's board of directors comprises two types of representatives: Sartorius Stedim inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Stedim's management team and ensure that shareholders' interests are well served. Sartorius Stedim's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Stedim's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rene Faber, CEO DIrector
Petra Kirchhoff, Head IR
Heiko Imhl, VP Relations
Petra Muller, Head Relations
Olivier Guitard, Head BPS
Joachim Kreuzburg, Chairman CEO
John Mackay, Sales Marketing
Benedikt Orzelek, Head Relations
Rainer Lehmann, CFO Board

Sartorius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sartorius Stedim a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Sartorius Stock Analysis

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.